Arizona State Retirement System Acquires 23,439 Shares of Tilray Inc (NASDAQ:TLRY)

Arizona State Retirement System grew its holdings in Tilray Inc (NASDAQ:TLRY) by 9.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 261,233 shares of the company’s stock after buying an additional 23,439 shares during the quarter. Arizona State Retirement System’s holdings in Tilray were worth $347,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. BNP Paribas Financial Markets lifted its holdings in Tilray by 1,314.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,819,494 shares of the company’s stock worth $3,202,000 after buying an additional 1,690,827 shares in the last quarter. Point72 Asset Management L.P. acquired a new position in shares of Tilray during the third quarter valued at $1,348,000. Atria Wealth Solutions Inc. boosted its holdings in Tilray by 174.7% in the fourth quarter. Atria Wealth Solutions Inc. now owns 84,516 shares of the company’s stock valued at $112,000 after acquiring an additional 53,751 shares during the last quarter. Barclays PLC increased its position in Tilray by 600.4% in the third quarter. Barclays PLC now owns 204,144 shares of the company’s stock worth $359,000 after purchasing an additional 174,997 shares during the period. Finally, IFP Advisors Inc raised its holdings in Tilray by 107.5% during the 4th quarter. IFP Advisors Inc now owns 133,523 shares of the company’s stock worth $178,000 after purchasing an additional 69,184 shares during the last quarter. Institutional investors and hedge funds own 9.35% of the company’s stock.

Tilray Trading Up 3.5 %

TLRY opened at $0.61 on Friday. Tilray Inc has a twelve month low of $0.58 and a twelve month high of $2.97. The firm has a market cap of $571.88 million, a PE ratio of -2.03 and a beta of 2.13. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.58 and a current ratio of 2.54. The firm’s fifty day moving average is $0.98 and its two-hundred day moving average is $1.34.

Tilray (NASDAQ:TLRY) last posted its earnings results on Friday, January 10th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.03) by ($0.07). The business had revenue of $210.90 million for the quarter, compared to the consensus estimate of $216.34 million. Tilray had a negative return on equity of 4.40% and a negative net margin of 30.95%. The company’s revenue was up 8.7% compared to the same quarter last year. Equities research analysts anticipate that Tilray Inc will post -0.2 EPS for the current year.

Analyst Ratings Changes

Separately, Canaccord Genuity Group raised their target price on shares of Tilray from $2.00 to $3.00 and gave the company a “buy” rating in a research note on Monday, January 13th. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $2.70.

Tilray Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.